HB 1393

  • Pennsylvania House Bill
  • 2021-2022 Regular Session
  • Introduced in House
  • Passed House Jun 20, 2022
  • Passed Senate Oct 26, 2022
  • Signed by Governor Nov 03, 2022

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions.

Abstract

Bill Sponsors (28)

Covington

     
Cosponsor

Abney

     
Cosponsor

Votes


Actions


Nov 03, 2022

Senate

Approved by the Governor

Senate

Act No. 111 of 2022

Oct 27, 2022

Senate

Presented to the Governor

Oct 26, 2022

Senate

Signed in Senate

Senate

Signed in House

Senate

Third consideration and final passage

Oct 25, 2022

Senate

Re-reported as committed

Oct 18, 2022

Senate

Re-referred to APPROPRIATIONS

Senate

Second consideration

Sep 20, 2022

Senate

Reported as committed

Senate

First consideration

Jun 21, 2022

Senate

Referred to JUDICIARY

Jun 20, 2022

House

Third consideration and final passage

House

Re-reported as committed

Jun 15, 2022

House

Re-committed to APPROPRIATIONS

House

PN 3253 Second consideration, with amendments

Jun 14, 2022

House

Removed from table

May 24, 2022

House

PN 3145 Reported as amended

House

Laid on the table

House

First consideration

May 14, 2021

House

PN 1509 Referred to JUDICIARY

Bill Text

Bill Text Versions Format
Printer's No. 3253 MSWORD PDF HTML
Printer's No. 3145 MSWORD PDF HTML
Printer's No. 1509 MSWORD PDF HTML

Related Documents

Document Format
Senate Fiscal Note PDF
House Fiscal Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.